CPIX

CUMBERLAND PHARMACEUTICALS I

CPIX·230770109·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

CPIX (CUMBERLAND PHARMACEUTICALS I) is held by 21 institutional investors as of Q1 2026. Largest holders: RENAISSANCE TECHNOLOGIES LLC ($1.5M), VANGUARD CAPITAL MANAGEMENT LLC ($1.2M), DIMENSIONAL FUND ADVISORS LP ($898,167). Net institutional sentiment: Mixed.

21
Holders
Avg rating(4 Elite)
$5.2M
Total Value
57% (26)
Fund Consensus
13 buying - 10 selling
CPIXSmart Money Verdict
View all
Held by 21 funds
4 elite
Who's Trading
ActivistAKA.J. Kazimi38.4%Feb 9, 2026
ActivistICIntegrated Core Strategies (US) LLC4.0%Oct 30, 2025
InsiderKJKAZIMI A JBuy $44.85Aug 29, 2025
InsiderKKKrogulski KennethBuy $234.6Aug 29, 2025
InsiderJJJones JamesBuy $44.85Aug 29, 2025
InsiderYCYoung CarolineBuy $20.7Aug 29, 2025
InsiderKJKAZIMI A JBuy $45.11Aug 28, 2025
InsiderKKKrogulski KennethBuy $235.96Aug 28, 2025
InsiderJJJones JamesBuy $45.11Aug 28, 2025
InsiderYCYoung CarolineBuy $20.82Aug 28, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
470,696(-0.3%)$1.5M0.0%+46.38%
0
New
361,759$1.2M0.0%+29.48%
39
Increased
276,359(+1.5%)$898,1670.0%+181.15%
25
Increased
114,293(+6.5%)$371,4990.0%+38.00%
17
Decreased
58,458(-19.4%)$189,9880.0%+213.76%
0
Increased
56,891(+8.2%)$184,8960.0%+122.35%
17
New
45,623$148,2750.0%+29.48%
34
Increased
39,510(+17.2%)$128,4080.0%+169.51%
18
New
36,423$118,3750.0%+29.48%
30
New
24,006$78,0200.0%+29.48%
29
New
20,252$65,8190.0%+29.48%
32
Unchanged
19,603$63,7100.0%+12.20%
0
Increased
19,475(+11.4%)$63,2940.0%+216.57%
23
Decreased
16,643(-24.2%)$54,0900.0%+83.71%
0
New
14,607$47,4730.0%+29.48%
31
Decreased
11,085(-54.7%)$36,0260.0%+83.59%
0
Decreased
5,189(-66.3%)$16,8640.0%+54.02%
0
Unchanged
3,260$10,5950.0%+150.17%
0
New
100$3250.0%+29.48%
17
Unchanged
1$30.0%-6.91%
0

Showing 1-20 of 26

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used